Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Birch Grove is a New York-based alternative credit and investment management firm focused on corporate credit opportunities, including hedge fund, private credit, par credit, and collateralized loan obligation strategies. The firm has been described as a diversified alternative credit manager with capabilities across structured, performing, distressed, and private credit. Originally operated as AS Birch Grove LP and backed by American Securities, the business was acquired by Third Point in March 2025 and is now operating as TP Birch Grove, a wholly owned division or subsidiary of Third Point. Despite leadership ties to healthcare-focused investing backgrounds, Birch Grove itself is not a life sciences, biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Birch Grove.